Lyell Immunopharma, Inc. ($LYEL)
Filing Information
| Accession Number | 0002095702-26-000002 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 12, 2026 |
| Document Date | Feb 10, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
9,004
Total Value
$5,872.48
P&L
+inf% (+$167,300.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
VP, Corporate Controller | Common Stock | โ | Feb 10, 2026 | Grant/Award | 8,750 | $0.00 | $0.00 | 15,891 | Direct | โ | View Details | |
VP, Corporate Controller | Common Stock | โ | Feb 10, 2026 | Sale | 254 | $23.12 | $5,872.48 | 15,637 | Direct | โ | View Details |